CoChat

Neovascular age-related macular degeneration: intraocular inflammatory cytokines in the poor responder to ranibizumab treatment

Open access
Pongsachareonnont, Pear, Ying Kit Mak, Michael, Hurst, Cameron, Lam, Wai-Ching · 2018 · Clinical Ophthalmology

The DOI matches its Crossref record; 64 of the 67 references it cites were found in a registry or an index.

Abstract

Purpose: To determine the levels of interleukin (IL)-6, vascular endothelial growth factor-A, platelet-derived growth factor, placental growth factor (PLGF), and other cytokines in the aqueous fluid of patients with neovascular age-related macular degeneration who respond poorly to ranibizumab. Patients and methods: This is an observational, prospective study. Thirty-two eyes from 30 patients were included in the study: 11 patients who responded poorly to ranibizumab and were switched to aflibercept (AF group), 8 patients who received ranibizumab and photodynamic therapy (PDT group), and 13 patients who responded to ranibizumab (control group). Aqueous fluid samples were collected for analysis of cytokine levels at baseline and after 1, 2, and 3 months of treatment. The effect of treatment on cytokine levels was compared between the study groups and between different time points using a linear mixed-effect regression model. Results: In the AF group, there was an increase in vascular endothelial growth factor-C, IL-7, and angiopoeitin-2 levels ( P =0.01) and a decrease in intercellular adhesion molecule and IL-17 levels ( P =0.01) between baseline and 3 months. After adjustment for age, sex, race, and type of lesion at baseline, the PLGF level was higher ( P =0.02) and the IL-7 level was lower ( P =0.04) in the ranibizumab non-responder group than in the ranibizumab responder group. Conclusion: Switching from ranibizumab to aflibercept did not reduce intraocular levels of angiogenesis cytokines, but resulted in improvement of central subfield thickness. PLGF levels were higher in poor responders to ranibizumab. The response of lesions to medication might be related to the stage of choroidal neovascularization. Trial registration: www.ClinicalTrial.gov (NCT02218177c). Keywords: neovascular age-related macular degeneration, choroidal neovascularization, anti-VEGF non-responder, poor responder, ranibizumab and AMD

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.2147/opth.s171636

Cites

64 of 64 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Histogram of gamma distribution range and prediction values below LOD of VEGF-C. Abbreviations: LOD, limit of detection; VEGF, vascular endothelial growth factor.
Figure 1 Histogram of gamma distribution range and prediction values below LOD of VEGF-C. Abbreviations: LOD, limit of detection; VEGF, vascular endothelial growth factor.CC BY-NC · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 64 references

Research works printed but not linked: 2

  1. [28]Robert CP Monte Carlo Methods Wiley Online Library 2004
  2. [53]Izumi-Nagai K Nagai N Ozawa Y Interleukin-6 receptor-mediated activation of signal transducer and activator of transcription-3 (STAT3) promotes choroidal neovascularization Am J Pathol 2007 170 6 2149 2158 17525280 PMC1899441

Cited by

See all 34

Metadata

Authors
Pongsachareonnont, P., Ying Kit Mak, M., Hurst, C., & Lam, W.-C.
Affiliations
  • Thai Red Cross Society (TH)
  • Chulalongkorn University (TH)
  • University of Toronto (CA)
Corresponding author
Lam, Wai-Ching
Venue
Clinical Ophthalmology
Published
2018-09
Volume
Volume 12
Pages
1877-1885
ISSN
  • 1177-5467 (ISSN-L)
  • 1177-5483
OpenAlex
W2894158365
Cited by
34
References
67
Citations by year
2026: 2 · 2025: 4 · 2024: 6 · 2023: 2 · 2022: 5 · 2021: 7 · 2020: 4 · 2019: 3 · 2018: 1
FWCI
3.77
Type
journal article
Language
en
Open access
Locations
  • Clinical ophthalmology (publishedVersion, cc-by-nc)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • Dove Medical Press (Taylor and Francis Group) (submittedVersion, cc-by-nc)
Topics
  • Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
  • Health Sciences › Medicine › Ophthalmology › Ocular Diseases and Behçet’s Syndrome
  • Health Sciences › Medicine › Ophthalmology › Retinal and Macular Surgery
Keywords
neovascular age-related macular degeneration, choroidal neovascularization, anti-VEGF therapy, aflibercept, aqueous humor, IL-7, placental growth factor, vascular endothelial growth factor, angiogenesis, photodynamic therapy, treatment response

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.